Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-25

Clinical Trial Update: Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring olfactory and neurosensory rehabilitation for COVID-19-related smell dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ivan FN Hung MD | Conditions: Coronavirus Disease 2019 | Phase 2 | Status: UNKNOWN